Medtech Biggest Casualty In Swiss/EU Uncertainty As Worst-Case Scenario Looms
Executive Summary
Eighteen years of free trade threatens to come to a sudden stop, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.
You may also be interested in...
MDR Delay: Adoption Now A Formality Following European Parliament Vote
EU industry will be celebrating, albeit in lockdown, as the EU proposal for a one-year delay to the MDR has made it through the European Parliament and is on track to become law within the next month.
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.